Anthropic’s rapid revenue expansion from its Claude large language models underpins trader consensus around a $1.75–2.25 trillion IPO valuation. The company reported a $47 billion annualized run rate in May 2026 after surging from roughly $9 billion at the end of 2025, with projections pointing toward $100–120 billion by year-end and $190–200 billion by 2028. Its May Series H round at a $965 billion post-money valuation, combined with confidential S-1 filing in June and plans for a $15 billion revolving credit facility, reinforced expectations of one of the largest-ever listings. Recent reports of a delayed timeline—marketing now slated for mid-October at the earliest, with a possible November debut before U.S. midterms—have introduced modest schedule uncertainty without materially shifting the market-implied range, as strong enterprise adoption and competitive positioning versus OpenAI continue to support premium multiples on forward revenue.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano$1.75–$2.00T 55%
$2.00–$2.25T 39.4%
$1.50–$1.75T 7.8%
$1.25–$1.50T 1.3%
$34,373 Wol.
$34,373 Wol.
Dec 31, 2027
<$1.25T
<1%
$1.25–$1.50T
1%
$1.50–$1.75T
8%
$1.75–$2.00T
55%
$2.00–$2.25T
39%
$2.25–$2.50T
<1%
$2.50T+
1%
No IPO by December 31, 2027
<1%
$1.75–$2.00T 55%
$2.00–$2.25T 39.4%
$1.50–$1.75T 7.8%
$1.25–$1.50T 1.3%
$34,373 Wol.
$34,373 Wol.
Dec 31, 2027
<$1.25T
$1,158 Wol.
<1%
$1.25–$1.50T
$1,608 Wol.
1%
$1.50–$1.75T
$5,455 Wol.
8%
$1.75–$2.00T
$13,570 Wol.
55%
$2.00–$2.25T
$8,524 Wol.
39%
$2.25–$2.50T
$1,263 Wol.
<1%
$2.50T+
$1,499 Wol.
1%
No IPO by December 31, 2027
$1,297 Wol.
<1%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion from its Claude large language models underpins trader consensus around a $1.75–2.25 trillion IPO valuation. The company reported a $47 billion annualized run rate in May 2026 after surging from roughly $9 billion at the end of 2025, with projections pointing toward $100–120 billion by year-end and $190–200 billion by 2028. Its May Series H round at a $965 billion post-money valuation, combined with confidential S-1 filing in June and plans for a $15 billion revolving credit facility, reinforced expectations of one of the largest-ever listings. Recent reports of a delayed timeline—marketing now slated for mid-October at the earliest, with a possible November debut before U.S. midterms—have introduced modest schedule uncertainty without materially shifting the market-implied range, as strong enterprise adoption and competitive positioning versus OpenAI continue to support premium multiples on forward revenue.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Rynek otwarty: Aug 19, 2026, 9:45 AM ET
Wolumen
$34,373Data zakończenia
Jan 1, 2028Rynek otwarty
Aug 19, 2026, 9:45 AM ETRozstrzygający
0x69c47De9D...This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion from its Claude large language models underpins trader consensus around a $1.75–2.25 trillion IPO valuation. The company reported a $47 billion annualized run rate in May 2026 after surging from roughly $9 billion at the end of 2025, with projections pointing toward $100–120 billion by year-end and $190–200 billion by 2028. Its May Series H round at a $965 billion post-money valuation, combined with confidential S-1 filing in June and plans for a $15 billion revolving credit facility, reinforced expectations of one of the largest-ever listings. Recent reports of a delayed timeline—marketing now slated for mid-October at the earliest, with a possible November debut before U.S. midterms—have introduced modest schedule uncertainty without materially shifting the market-implied range, as strong enterprise adoption and competitive positioning versus OpenAI continue to support premium multiples on forward revenue.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Wolumen
$34,373Data zakończenia
Jan 1, 2028Rynek otwarty
Aug 19, 2026, 9:45 AM ETRozstrzygający
0x69c47De9D...Anthropic’s rapid revenue expansion from its Claude large language models underpins trader consensus around a $1.75–2.25 trillion IPO valuation. The company reported a $47 billion annualized run rate in May 2026 after surging from roughly $9 billion at the end of 2025, with projections pointing toward $100–120 billion by year-end and $190–200 billion by 2028. Its May Series H round at a $965 billion post-money valuation, combined with confidential S-1 filing in June and plans for a $15 billion revolving credit facility, reinforced expectations of one of the largest-ever listings. Recent reports of a delayed timeline—marketing now slated for mid-October at the earliest, with a possible November debut before U.S. midterms—have introduced modest schedule uncertainty without materially shifting the market-implied range, as strong enterprise adoption and competitive positioning versus OpenAI continue to support premium multiples on forward revenue.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania